Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments

被引:102
作者
Melese, M
Chidambaram, JD
Alemayelm, W
Lee, DC
Yi, EH
Cevallos, V
Zhou, ZX
Donnellan, C
Saidel, M
Whitcher, JP
Gaynor, BD
Lietman, TM
机构
[1] Univ Calif San Francisco, FI Proctor Fdn, WHO Collaborating Ctr, San Francisco, CA 94143 USA
[2] ORBIS Int, Addis Ababa, Ethiopia
[3] Univ Calif San Francisco, Inst Global Hlth, Dept Ophthalmol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Inst Global Hlth, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 06期
关键词
D O I
10.1001/jama.292.6.721
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Mass antibiotic administrations for ocular chlamydial infection play a key role in the World Health Organization's trachoma control program. Mathematical models suggest that it is possible to eliminate trachoma locally with repeat mass treatment, depending on the coverage level of the population, frequency of mass treatments, and rate that infection returns into a community after each mass treatment. Precise estimates of this latter parameter have never been reported. Objective To determine the rate at which chlamydial infection returns to a population after mass treatment and to estimate the treatment frequency required for elimination of ocular chlamydia from a community. Design, Setting, and Participants Longitudinal cohort study of 24 randomly selected villages from the Gurage Zone in Ethiopia conducted February 2003 to October 2003. A total of 1332 children aged 1 to 5 years were monitored for prevalence of ocular chlamydial infection pretreatment and 2 and 6 months posttreatment. Interventions All individuals older than 1 year were eligible for single-dose oral azithromycin treatment. Pregnant women were offered tetracycline eye ointment. Main Outcome Measures Prevalence of ocular chlamydial infection, measured by polymerase chain reaction, in children aged 1 to 5 years, in each of 24 villages at each time point was used to estimate the rate of return of infection and the treatment frequency necessary for elimination. Results The prevalence of. infection was 56.3% pretreatment (95% confidence interval [CI], 47.5%-65.1%), 6.7% 2 months posttreatment (95% Cl, 4.2%-9.2%), and 11.0% 6 months posttreatment (95% CI, 7.3%-14.7%). Infection returned after treatment at an exponential rate of 12.3% per month (95% Cl, 4.6%-19.9% per month). The minimum treatment frequency necessary for elimination was calculated to be once every 11.6 months (95% Cl, 7.2-30.9 months), given a coverage level of 80%. Thus, biannual treatment, already being performed in some areas, was estimated to be more than frequent enough to eventually eliminate infection. Conclusion The rate at which ocular chlamydial infection returns to a community after mass treatment suggests that elimination of infection in a hyperendemic area is feasible with biannual mass antibiotic administrations and attainable coverage levels.
引用
收藏
页码:721 / 725
页数:5
相关论文
共 27 条
[1]   Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? [J].
Bird, M ;
Dawson, CR ;
Schachter, JS ;
Miao, YH ;
Shama, A ;
Osman, A ;
Bassem, A ;
Lietman, TM .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) :1669-1673
[2]  
Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156
[3]   Reduction of trachoma in a sub-Saharan village in absence of a disease control programme [J].
Dolin, PJ ;
Faal, H ;
Johnson, GJ ;
Minassian, D ;
Sowa, S ;
Day, S ;
Ajewole, J ;
Mohamed, AA ;
Foster, A .
LANCET, 1997, 349 (9064) :1511-1512
[4]  
Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22
[5]   Review of the evidence base for the 'F' and 'E' components of the SAFE strategy for trachoma control [J].
Emerson, PM ;
Cairncross, S ;
Bailey, RL ;
Mabey, DCW .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2000, 5 (08) :515-527
[6]  
Farid M. A., 1980, World Health Forum, V1, P8
[7]  
FRIEDERICH R, 1982, ANN OPHTHALMOL, V14, P38
[8]   Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal [J].
Fry, AM ;
Jha, HC ;
Lietman, TM ;
Chaudhary, JSP ;
Bhatta, RC ;
Elliott, J ;
Hyde, T ;
Schuchat, A ;
Gaynor, B ;
Dowell, SF .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) :395-402
[9]   Eliminating trachoma in areas with limited disease [J].
Gaynor, BD ;
Miao, YH ;
Cevallos, V ;
Jha, H ;
Chaudary, JSP ;
Bhatta, R ;
Osaki-Holm, S ;
Yi, E ;
Schachter, J ;
Whitcher, JP ;
Lietman, T .
EMERGING INFECTIOUS DISEASES, 2003, 9 (05) :596-598
[10]  
Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17